The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort Analysis
Background: To investigate the impact of COVID-19 outbreak on the diagnosis and treatment of non-muscle invasive bladder cancer (NMIBC). Methods: A retrospective analysis was performed using an Italian multi-institutional database of TURBT patients with high-risk urothelial NMIBC between January 201...
Guardado en:
Ejemplares similares
-
Kaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the Literature
por: Felice Crocetto, et al.
Publicado: (2021) -
Improved Non-Invasive Diagnosis of Bladder Cancer with an Electronic Nose: A Large Pilot Study
por: PierFrancesco Bassi, et al.
Publicado: (2021) -
Crashworthiness of a Composite Bladder Fuel Tank for a Tilt Rotor Aircraft
por: Carmen Simona Paciello, et al.
Publicado: (2021) -
En-bloc resection of urinary bladder tumour – a prospective controlled multicentre observational study
por: Sławomir Poletajew, et al.
Publicado: (2020) -
Long-Term Experience with Hyperthermic Chemotherapy (HIVEC) Using Mitomycin-C in Patients with Non-Muscle Invasive Bladder Cancer in Spain
por: Ana Plata, et al.
Publicado: (2021)